Fasken | Canada, United Kingdom | 13 Aug 2014
For the best part of 10 years, since the judgment of Lord Hoffmann in Kirin-Amgen v Hoescht Marion Roussel, it has been widely assumed that there is…
Fasken | Canada, United Kingdom | 22 Jan 2014
The Court of Appeal has now revisited the Glaxo v Genentech guidelines in light of the Supreme Court's judgments in Virgin Atlantic. It did so…
Fasken | Canada, United Kingdom | 14 Apr 2011
The award of £17.5 million damages to Apotex under a cross-undertaking in damages given by Servier has been set aside by the High Court on the basis of public policy and the rule of law that no action can arise from an illegal or immoral act – here the manufacture of a generic medicine that infringed a valid foreign patent.